A May 2024 study in *Environmental Health Perspectives* connects prenatal PFAS exposure to impaired maternal beta cell function, while new EPA regulations and EU reports intensify global regulatory ac...
NIH-funded research shows prenatal PFAS exposure increases maternal beta-cell dysfunction risk by 15-20% a decade postpartum, with epigenetic changes as a key mechanism. Emerging evidence connects pre...
New research shows prenatal PFAS exposure reduces maternal HOMA-β by 34%, with epigenetic and oxidative stress markers providing mechanistic insights. Global regulatory responses are evolving. A grou...
Recent studies link PFAS to a 30% higher risk of gestational diabetes, with new detox protocols and EPA regulations aiming to reduce exposure. Emerging research highlights PFAS as significant endocrin...
Recent studies reveal that prenatal PFAS exposure is associated with impaired maternal beta cell function, increasing risks for gestational diabetes and metabolic disorders. New research highlights th...
